Table 6.
Comparison of microarray analysis between two studies
| Gene | Fold change in John-Aryankalayil et al | Fold change in our study |
| Significantly regulated in current study (p < 0.05) | ||
| SILV (silver homolog) | 2.2 | 2.3 |
| CD31 (PECAM1) | 2.1 | 2.2 |
| C5orf13 | 2.5 | 2.2 |
| RBP1 | 3.6 | 2.0 |
| Von Willebrand factor | 2.5 | 2.0 |
| RAB31 | 2.0 | 1.7 |
| Clathrin (CLTB) | 2.4 | 1.7 |
| DAB2 | 2.1 | 1.5 |
| S100 A9 (calgranulin B) | 2.2 | 1.4 |
| MAP 17 | 2.4 | 1.4 |
| MIP-4 | 4.9 | 1.4 |
| ECM1 | 3.2 | 1.3 |
| COMP | 2.0 | 1.3 |
| versican | 3.3 | 1.2 |
| TRAP100 | 5.0 | 1.2 |
| CD32 receptor | 2.9 | 1.2 |
| mRNA, clone AL050154 | 2.8 | 1.1 |
| CLIC2 | 0.5 | 1.1 |
| Prostaglandin F2alpha receptor | 3.2 | 1.1 |
| Not significantly regulated in current study (p > 0.05) | ||
| NDRG4 | 3.1 | 1.1 |
| Carbonic anhydrase CA1 | 0.5 | 1.1 |
| ABCG1 | 2.3 | 1.1 |
| ADPRTL2 | 2.3 | 1.1 |
| Casein kinase II | 2.5 | 1.0 |
| Collagen III | 4.1 | 1.0 |
| Fibronectin | 8.5 | 1.0 |
| LZTR1 | 2.2 | 1.0 |
| Collagen VI | 2.1 | 1.0 |
| Myosin heavy chain II | 3.1 | 0.9 |
| FUBP | 0.5 | 0.9 |
| Ephrin-A1 | 0.5 | 0.9 |
| Per1 | 0.5 | 0.9 |
| Lipocalin 2 | 2.4 | 0.9 |